| Completed | Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma Renal Cell Cancer Metastatic | — | 2025-05-13 |
| Recruiting | Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors. Genitourinary Cancers | — | 2024-12-13 |
| Recruiting | Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibr Muscle-invasive Bladder Cancer | Phase 2 | 2023-03-07 |
| Completed | SOGUG-AVELUMAB_RWD Metastatic Urothelial Carcinoma | — | 2022-09-05 |
| Active Not Recruiting | Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer Urothelial Cancer | Phase 2 | 2022-07-06 |
| Completed | Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma Locally Advanced or Metastatic Urothelial Carcinoma | Phase 2 | 2020-12-23 |
| Completed | Description of the Population With Genitourinary Tumors and COVID-19 Covid19, Genito Urinary Cancer | — | 2020-12-18 |
| Completed | Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients Old Age; Debility, Renal Carcinoma Metastatic | Phase 2 | 2020-02-17 |
| Completed | Spanish Real-World Evidence Cabozantinib Renal Cell Carcinoma | — | 2019-10-23 |
| Active Not Recruiting | Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer Bladder Cancer | Phase 2 | 2019-09-18 |
| Unknown | A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer Metastatic Hormone-sensitive Prostate Cancer | Phase 2 / Phase 3 | 2019-02-11 |
| Completed | Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated Invasive Bladder Cancer | Phase 2 | 2018-11-19 |
| Completed | Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) Bladder Cancer | Phase 2 | 2018-11-16 |
| Completed | Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMA Prostate Cancer Metastatic | Phase 2 | 2018-02-06 |
| Completed | Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Trea Clear Cell Renal Carcinoma | Phase 2 | 2017-05-10 |
| Completed | Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classifi Metastatic Renal Cell Carcinoma | — | 2016-12-20 |
| Terminated | Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Te Renal Cell Carcinoma | — | 2015-10-01 |
| Completed | Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer Hormone-refractory Prostate Cancer | Phase 2 | 2015-02-05 |
| Terminated | Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) Penile Squamous Cell Carcinoma Stage IV | Phase 2 | 2015-01-01 |
| Completed | Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Ca Metastatic Renal Cell Carcinoma | — | 2014-11-01 |
| Completed | Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First Metastatic Renal Cell Carcinoma | — | 2014-10-01 |
| Completed | Abiraterone Acetate in Combination With Docetaxel After Disease Progression to Abiraterone Acetate in Metastat Metastatic Prostate Cancer | Phase 2 | 2014-02-07 |
| Completed | Study of Weekly Cabazitaxel for Advanced Prostate Cancer Hormone Refractory Prostate Cancer | Phase 2 | 2012-05-01 |
| Completed | Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer Carcinoma, Transitional Cell | Phase 2 | 2012-02-01 |
| Completed | Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcino Adrenocortical Carcinoma | Phase 2 | 2012-01-01 |
| Completed | Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma Advanced Renal Cell Carcinoma | Phase 1 / Phase 2 | 2011-07-11 |
| Unknown | Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer Prostate Cancer Stage III, Prostate Cancer Stage IV | Phase 2 | 2008-12-18 |
| Completed | Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to C Carcinoma Renal Cells | Phase 2 | 2008-02-01 |
| Completed | Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent Bladder Cancer | Phase 1 | 2007-12-01 |
| Completed | Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC Carcinoma, Renal Cell | Phase 2 | 2006-11-01 |